Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients.

Chiang, Ying-Cheng

Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients. [electronic resource] - Endocrine-related cancer Apr 2013 - 213-27 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1479-6821

10.1530/ERC-12-0117 doi


Antineoplastic Agents--pharmacology
Apoptosis
Biomarkers, Tumor
Carcinoma, Ovarian Epithelial
Cell Line, Tumor
Cisplatin--pharmacology
Cytoskeletal Proteins
Drug Resistance, Neoplasm
Epigenomics
Female
Gene Silencing
Humans
Methylation
Neoplasms, Glandular and Epithelial--genetics
Ovarian Neoplasms--genetics
Paclitaxel--pharmacology
Prognosis
RNA, Small Interfering--genetics
Tumor Suppressor Proteins--genetics